Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

The researchers observed “significant” weight regain at eight, 12, and 20 weeks after discontinuation. They deduced that most patients gain back the weight they initially lost for an average of 20 ...

This article delves into the approved weight loss drugs in India, their costs, and the growing market for such medications.

The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.

A WOMAN who shed a whopping 6st in just nine months has shared the secret behind not pilling back all the pounds when eating out. Lucy Davies kickstarted her weight loss journey with the popular ...

When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...

LinkGevity is among a cluster of biotech firms in Cambridge working on potential longevity treatments. They include clock.bio ...

Sally Love has always enjoyed a drink - but, like many, it was during the Covid pandemic that her alcohol intake began to spiral.

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

"My scene was supposed to be funny, and it got nothing in the f---ing Chinese Theatre," the comedian says while discussing ...